Suchergebnisse - "Baudy, Andreas R"

PubPharm (18)

1

Perspectives on the evaluation and adoption of complex in vitro models in drug development : Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate)

enthalten in: ALTEX | 2022

von Baran, S. | Brown, P. | Baudy, A. | +24

2

Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry

enthalten in: Lab on a chip | 2020

von Baudy, A. | Otieno, M. | Hewitt, P. | +6

3

mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells

enthalten in: Cancer cell | 2016

von Pusapati, R. | Daemen, A. | Wilson, C. | +7

CommentIn: Cancer Discov. 2016 May;6(5):469. - PMID 27056835

4

mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells

enthalten in: Cancer cell | 2016

von Pusapati, R. | Daemen, A. | Wilson, C. | +7

5

Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κB inhibitory efficacy from glucocorticoid response element-associated side effects

enthalten in: The Journal of pharmacology and experimental therapeutics | 2012

von Baudy, A. | Reeves, E. | Damsker, J. | +14

6

The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant

enthalten in: EJNMMI research | 2012

von Williams, S. | Flores-Mercado, J. | Baudy, A. | +2

7

The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant

enthalten in: EJNMMI Research | 2012

von Williams, S. | Flores-Mercado, J. | Baudy, A. | +2

8

FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973

enthalten in: EJNMMI research | 2012

von Baudy, A. | Dogan, T. | Flores-Mercado, J. | +4

9

FDG-PET is a good biomarker of both early response and acquired resistance in $ BRAF^{V600} $ mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973

enthalten in: EJNMMI Research | 2012

von Baudy, A. | Dogan, T. | Flores-Mercado, J. | +4

10

Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through

enthalten in: The American journal of pathology | 2011

von Hoffman, E. | Bronson, A. | Levin, A. | +4